Al Nahdi Medical Company SCJSC
SAU:4164
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
127
153.2
|
Price Target |
|
We'll email you a reminder when the closing price reaches SAR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Al Nahdi Medical Company SCJSC stock under the Base Case scenario is 121.76 SAR. Compared to the current market price of 129.2 SAR, Al Nahdi Medical Company SCJSC is Overvalued by 6%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Al Nahdi Medical Company SCJSC
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Al Nahdi Medical Company SCJSC cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Al Nahdi Medical Company SCJSC
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Al Nahdi Medical Company SCJSC
Balance Sheet Decomposition
Al Nahdi Medical Company SCJSC
Current Assets | 3B |
Cash & Short-Term Investments | 728.4m |
Receivables | 291.2m |
Other Current Assets | 2B |
Non-Current Assets | 2.7B |
Long-Term Investments | 254.3m |
PP&E | 2.4B |
Intangibles | 61.2m |
Current Liabilities | 1.8B |
Accounts Payable | 1.2B |
Accrued Liabilities | 220.2m |
Other Current Liabilities | 412.1m |
Non-Current Liabilities | 1.3B |
Long-Term Debt | 955.7m |
Other Non-Current Liabilities | 388.9m |
Earnings Waterfall
Al Nahdi Medical Company SCJSC
Revenue
|
9.1B
SAR
|
Cost of Revenue
|
-5.6B
SAR
|
Gross Profit
|
3.5B
SAR
|
Operating Expenses
|
-2.6B
SAR
|
Operating Income
|
919.8m
SAR
|
Other Expenses
|
-55.8m
SAR
|
Net Income
|
864m
SAR
|
Free Cash Flow Analysis
Al Nahdi Medical Company SCJSC
SAR | |
Free Cash Flow | SAR |
Profitability Score
Profitability Due Diligence
Al Nahdi Medical Company SCJSC's profitability score is 65/100. The higher the profitability score, the more profitable the company is.
Score
Al Nahdi Medical Company SCJSC's profitability score is 65/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Al Nahdi Medical Company SCJSC's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Score
Al Nahdi Medical Company SCJSC's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Al Nahdi Medical Company SCJSC
According to Wall Street analysts, the average 1-year price target for Al Nahdi Medical Company SCJSC is 148.1 SAR with a low forecast of 136.61 SAR and a high forecast of 176.4 SAR.
Dividends
Current shareholder yield for Al Nahdi Medical Company SCJSC is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Nahdi Medical Co. operates pharmacy stores. The company is headquartered in Jeddah, Makkah. The company went IPO on 2022-03-22. The firm is engaged in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods and medical equipment. The firm operates two operating segments: Front Shop and Pharma. The firm provides medicine, wellness, mom & baby, beauty and other wide-ranging FMCG products. The firm provides omni-health services through its polyclinics, express clinics, telemedicine, labs, and home healthcare. The firm operates approximately 1,150 stores in 144 cities and towns in the Kingdom of Saudi Arabia and the United Arab Emirates. The Company’s subsidiaries include Al Nahdi Care, Sakhaa Golden Company, and Nahdi Investment Company.
Officers
The intrinsic value of one Al Nahdi Medical Company SCJSC stock under the Base Case scenario is 121.76 SAR.
Compared to the current market price of 129.2 SAR, Al Nahdi Medical Company SCJSC is Overvalued by 6%.